Status:
COMPLETED
Hysteroscopy and Misoprostol Project
Lead Sponsor:
Ullevaal University Hospital
Conditions:
Uterine Hemorrhage
Eligibility:
FEMALE
18-73 years
Phase:
PHASE3
Brief Summary
To investigate if self-inserted vaginal misoprostol prior to outpatient hysteroscopy will lead to satisfactory cervical ripening, compared to placebo.
Detailed Description
In gynaecological practice, diagnostic and therapeutic hysteroscopy is one of the most common methods for diagnosing intrauterine pathology. The complications encountered during hysteroscopy, such as ...
Eligibility Criteria
Inclusion
- All patients who are referred to outpatient hysteroscopy, and who have given informed consent, will be eligible for study recruitment.
Exclusion
- Women who are unable to communicate in Norwegian
- Women with a known allergy to misoprostol
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00363389
Start Date
September 1 2006
End Date
May 1 2007
Last Update
August 7 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynaecological Department, Ullevål University Hospital
Oslo, Norway, N-0407